PH12015502000A1 - Processes and intermediates for preparing a medicament - Google Patents

Processes and intermediates for preparing a medicament

Info

Publication number
PH12015502000A1
PH12015502000A1 PH12015502000A PH12015502000A PH12015502000A1 PH 12015502000 A1 PH12015502000 A1 PH 12015502000A1 PH 12015502000 A PH12015502000 A PH 12015502000A PH 12015502000 A PH12015502000 A PH 12015502000A PH 12015502000 A1 PH12015502000 A1 PH 12015502000A1
Authority
PH
Philippines
Prior art keywords
intermediates
processes
medicament
preparing
useful
Prior art date
Application number
PH12015502000A
Inventor
Pye Philip
Ben Haim Cyril
Conza Matteo
Houpis Ioannis Nicolaos
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=50239639&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PH12015502000(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from PCT/EP2014/054621 external-priority patent/WO2014139970A1/en
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of PH12015502000A1 publication Critical patent/PH12015502000A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings

Abstract

Disclosed is a process for the preparation of the following compounds: (I), (II) where R1, R1a and R2a have the definitions in the description, as well as a process to prepare other intermediates that may be useful to synthesise downstream products, especially compounds that are useful as medicaments, for instance Bruton's tyrosine kinase (Btk) inhibitors such as ibrutinib. Also disclosed are other processes, other intermediates and compounds per se.
PH12015502000A 2013-03-15 2015-09-08 Processes and intermediates for preparing a medicament PH12015502000A1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201361786842P 2013-03-15 2013-03-15
EP13159470 2013-03-15
EP13197813 2013-12-17
PCT/EP2014/054621 WO2014139970A1 (en) 2013-03-15 2014-03-11 Processes and intermediates for preparing a medicament

Publications (1)

Publication Number Publication Date
PH12015502000A1 true PH12015502000A1 (en) 2016-01-11

Family

ID=50239639

Family Applications (1)

Application Number Title Priority Date Filing Date
PH12015502000A PH12015502000A1 (en) 2013-03-15 2015-09-08 Processes and intermediates for preparing a medicament

Country Status (5)

Country Link
CL (1) CL2015002668A1 (en)
HK (1) HK1216178A1 (en)
IL (1) IL240533A0 (en)
PE (1) PE20211448A1 (en)
PH (1) PH12015502000A1 (en)

Also Published As

Publication number Publication date
PE20211448A1 (en) 2021-08-05
IL240533A0 (en) 2015-10-29
CL2015002668A1 (en) 2016-03-04
HK1216178A1 (en) 2016-10-21
NZ711026A (en) 2021-01-29

Similar Documents

Publication Publication Date Title
MX2015012731A (en) Processes and intermediates for preparing a medicament.
MX2021007432A (en) Compounds and compositions for inhibiting the activity of shp2.
JO3453B1 (en) Benzamide Derivatives FOR INHIBITING THE ACTIVITY OF ABL1, ABL2 AND BCR-ABL1
SA515360007B1 (en) Heteroaromatic compounds as bruton's tyrosine kinase (BTK) inhibitors
EA030383B9 (en) Bicyclically substituted uracils, processes for preparation thereof, use thereof, medicament and method for treatment using same
MX368781B (en) Compound inhibiting kinase activities of btk and/or jak3.
MY173877A (en) Branched 3-phenylpropionic acid derivatives and the use thereof
MX336214B (en) Pyrrolotriazinone derivatives as pi3k inhibitors.
MX357305B (en) Compounds and compositions for inhibiting the activity of abl1, abl2 and bcr-abl1.
MD20150048A2 (en) Pyrrolotriazinone derivatives as PI3K inhibitors
MX348470B (en) Substituted annellated pyrimidine and the use thereof.
EA201492005A1 (en) BENZAMIDE DERIVATIVES TO INHIBIT ACTIVITY ABL1, ABL2 AND BCR-ABL1
MX2013011691A (en) Inhibitors of viral replication, their process of preparation and their therapeutical uses.
MX2016000794A (en) High potency pancreatin pharmaceutical compositions.
MY175804A (en) Estra-1,3,5(10),16-tetraene-3-carboxamide derivatives, process for preparation thereof, pharmaceutical preparations comprising them, and use thereof for production of medicaments
UA113962C2 (en) PHARMACEUTICAL COMPOSITION CONTAINING APOMORPHINE AS AN ACTIVE INGREDIENT
MX2016000480A (en) High potency pancreatin pharmaceutical compositions.
TN2015000095A1 (en) Macrolide derivatives, preparation thereof and therapeutic use thereof
PH12015502000A1 (en) Processes and intermediates for preparing a medicament
TN2013000128A1 (en) Process for preparing pan-cdk inhibitors of the formula (1), and intermediates in the preparation
TN2014000085A1 (en) Substituted annellated pyrimidine and the use thereof